Description
Key facts
Cell type:HEK-293T,
Species or organism:Human,
Tissue:Kidney,
Knockout validation:Sanger Sequencing,
Mutation description:Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1.
Product details:
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation:
Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10).
This means that the protein of interest is denatured.
If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions:
Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our
limited use license
patent pages
Properties and Storage Information:
Gene name-AGA, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Sanger Sequencing, Zygosity-Homozygous, Shipped at conditions-Ambient - Can Ship with Ice, Appropriate short-term storage conditions--20°C, Appropriate long-term storage conditions--20°C
Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
The AGA protein also known as Aspartylglucosaminidase has an important role in catalyzing the hydrolysis of glycosylasparagine to glucosamine and aspartic acid. This activity occurs predominantly in the lysosomes. The AGA gene encodes this enzyme which has a molecular mass of approximately 35 kDa. It is expressed in a variety of tissues including the liver and kidney where it contributes significantly to protein degradation.
Biological function summary
Enzymes like AGA help in glycoprotein catabolism which is an essential process for cellular maintenance and function. AGA functions as a homodimer and is an integral part of the lysosomal enzyme complex. This complex ensures proper degradation of N-linked oligosaccharides from glycoproteins following cellular internalization. Disruption in AGA's function results in accumulation of undigested glycoproteins which may affect normal cellular processes.
Pathways
AGA's activity ties into the lysosomal degradation pathway significantly influencing the catabolic reduction of glycoproteins. It is closely related to other lysosomal enzymes such as cathepsins. AGA’s regulation is linked to cellular recycling and energy balance pathways transitioning the breakdown products of glycoproteins into reusable components for other metabolic processes.
AGA is closely related to the condition known as Aspartylglucosaminuria. This rare inherited metabolic disorder results in the accumulation of glycoasparagines due to AGA deficiency leading to various symptoms including intellectual disability and skeletal abnormalities. In this disorder AGA malfunctions can also influence the activity of other lysosomal enzymes exacerbating the cellular effects of the accumulated substrates.
